Get the Stockscreener App
1.849
3.88%
0.069
Cytomed Therapeutics Ltd stock is traded at $1.849, with a volume of 9,980.
It is up +3.88% in the last 24 hours and down -8.47% over the past month.
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
See More
Previous Close:
$1.78
Open:
$1.8
24h Volume:
9,980
Relative Volume:
0.95
Market Cap:
$20.54M
Revenue:
-
Net Income/Loss:
$-3.15M
P/E Ratio:
-6.0583
EPS:
-0.3052
Net Cash Flow:
$-2.23M
1W Performance:
+2.72%
1M Performance:
-8.47%
6M Performance:
-33.96%
1Y Performance:
+15.56%
1-Day Range:
$1.7884
$1.849
1-Week Range:
$1.65
$1.849
52-Week Range:
$1.20
$4.0499
Cytomed Therapeutics Ltd Stock (GDTC) Company Profile
Name
Cytomed Therapeutics Ltd
Sector
Industry
Phone
-
Address
-
Compare GDTC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GDTC
Cytomed Therapeutics Ltd
|
1.849 | 20.54M | 0 | -3.15M | -2.23M | -0.3052 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Cytomed Therapeutics Ltd Stock (GDTC) Latest News
What institutional flow reveals about CytoMed Therapeutics Limited2025 Big Picture & Real-Time Chart Breakout Alerts - Newser
Medicus Pharma Ltd. Equity Warrant stock daily chart insightsWeekly Trade Recap & High Accuracy Investment Entry Signals - Newser
Identifying reversal signals in JKHY2025 Trading Volume Trends & Daily Stock Trend Watchlist - Newser
Detecting support and resistance levels for Public Storage2025 Key Lessons & Fast Exit and Entry Trade Guides - Newser
Institutional scanner results for CytoMed Therapeutics Limited2025 Price Action Summary & Fast Entry and Exit Trade Plans - Newser
CytoMed Therapeutics Limited stock chart pattern explainedTrade Performance Summary & Low Drawdown Investment Ideas - Newser
Momentum divergence signals in Reading International Inc. chartJuly 2025 Update & Verified Momentum Stock Watchlist - Newser
Using R and stats models for Chicago Atlantic BDC Inc. forecastingJuly 2025 Opening Moves & Safe Entry Zone Tips - Newser
How sentiment analysis helps forecast Westwood Holdings Group Inc.Market Trend Review & AI Driven Stock Reports - Newser
Visual analytics tools that track CytoMed Therapeutics Limited performanceGold Moves & AI Enhanced Trading Signals - Newser
How to manage a losing position in ZUMZBear Alert & Daily Price Action Insights - Newser
Is Indivior PLC forming a reversal patternPrice Action & Growth Focused Investment Plans - Newser
Visual trend scoring systems applied to Thermo Fisher Scientific Inc.July 2025 Sentiment & Entry Point Confirmation Alerts - Newser
Detecting support and resistance levels for CareCloud Inc.Weekly Profit Summary & Stepwise Trade Execution Plans - Newser
Institutional scanner results for PRA Group Inc.July 2025 Summary & High Conviction Buy Zone Alerts - Newser
Relative strength of Northland Power Inc. Preferred Security in sector analysisWeekly Trade Review & Step-by-Step Trade Execution Guides - Newser
Heatmap analysis for YSXT and competitorsEarnings Growth Summary & Fast Exit/Entry Strategy Plans - Newser
Risk adjusted return profile for Zimmer Biomet Holdings Inc. analyzedCPI Data & AI Based Buy/Sell Signal Reports - Newser
Custom watchlist performance reports with CytoMed Therapeutics Limited2025 Institutional Moves & Weekly Breakout Stock Alerts - Newser
Can ADC Therapeutics SA hit a new high this month2025 Year in Review & Weekly Watchlist for Consistent Profits - Newser
Combining machine learning predictions for Sezzle Inc.2025 Price Targets & AI Optimized Trading Strategy Guides - Newser
Using Ichimoku Cloud for Biomerica Inc. technicals2025 Price Momentum & High Accuracy Swing Trade Signals - Newser
Can technical indicators confirm TRVG’s reversalJuly 2025 Earnings & Fast Entry and Exit Trade Plans - Newser
Using AI based signals to follow CHRSTrade Entry Summary & Daily Entry Point Alerts - Newser
Is Shore Bancshares Inc. stock reversal real or fakeRecession Risk & Technical Pattern Recognition Alerts - Newser
CytoMed Therapeutics Limited Announces At-the-Market (ATM) Offering Program - Yahoo Finance
$4.3M Capital Raise: CytoMed Therapeutics Launches ATM Program After 2.5K New Blood Bank Customers - Stock Titan
Can trapped investors hope for a rebound in Via Renewables Inc.Market Growth Summary & Verified Entry Point Signals - Newser
Will CytoMed Therapeutics Limited bounce back from current supportSwing Trade & Community Verified Trade Signals - Newser
Full technical analysis of BKKT.WS stock2025 Price Momentum & Target Return Focused Stock Picks - Newser
Is it too late to sell Lifeward Ltd.2025 Biggest Moves & AI Powered Buy and Sell Recommendations - Newser
Price action breakdown for Bellevue Life Sciences Acquisition Corp. Equity WarrantPortfolio Return Summary & Daily Entry Point Trade Alerts - Newser
Using RSI to spot recovery in Affiliated Managers Group Inc.Sell Signal & Real-Time Buy Zone Alerts - Newser
Is it too late to sell CytoMed Therapeutics LimitedMarket Trend Report & Reliable Intraday Trade Plans - Newser
How to use Fibonacci retracement on CytoMed Therapeutics LimitedEntry Point & Free Community Consensus Stock Picks - Newser
What does recent volatility data suggest for The Goldman Sachs Group Inc.July 2025 Weekly Recap & Verified Momentum Stock Ideas - Newser
Using Ichimoku Cloud for CytoMed Therapeutics Limited technicalsJuly 2025 Trade Ideas & Fast Exit and Entry Strategy Plans - Newser
Has Landsea Homes Corporation Equity Warrant formed a bullish divergenceEarnings Growth Summary & Free Expert Approved Momentum Trade Ideas - Newser
Technical signs of recovery in Paranovus Entertainment Technology Ltd.Gap Down & Fast Entry and Exit Trade Plans - Newser
Exicure Inc. stock daily chart insightsMarket Movers & Proven Capital Preservation Methods - Newser
what makes cytomed therapeutics limited stock price move sharplyJuly 2025 Reactions & Growth Focused Stock Reports - Newser
Is It Too Late to Sell CytoMed Therapeutics LimitedJuly 2025 PostEarnings & High Accuracy Trade Signal Alerts - 선데이타임즈
What is the next catalyst for CytoMed Therapeutics LimitedIndex Update & Free Daily Entry Point Trade Alerts - thegnnews.com
How VTAK stock performs during market volatilitySell Signal & Verified Stock Trade Ideas - Newser
Real time scanner hits for CytoMed Therapeutics Limited explained2025 Price Momentum & Risk Controlled Daily Trade Plans - Newser
Is CytoMed Therapeutics Limited a candidate for recovery playRisk Aware Trading Ideas with Alert Levels - Newser
CytoMed Therapeutics (NASDAQ:GDTC) Trading Down 3.7% – Here’s What Happened - Defense World
Comparing CytoMed Therapeutics Limited in custom built stock radarsAI Pattern Recognition and Trade Prediction - Newser
How high can CytoMed Therapeutics Limited stock price go in 2025Buy and Hold Strategy for Capital Safety - Newser
CytoMed Therapeutics Limited stock trendline breakdownMonthly Long-Term Market Recap and Summary - Newser
Is it time to cut losses on CytoMed Therapeutics LimitedFree Momentum Based Equity Trading Plan - Newser
Cytomed Therapeutics Ltd Stock (GDTC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):